Burke-Blythedale Pediatric Neuroscience Research Collaboration

You are here

Visionary Valentino

Published Media: 
YouTube Video

Visionary Valentino

Burke-Blythedale Pediatric Neuroscience Research Collaboration Sets Sights on Innovative Rehab Project

Electronic music is made for dancing, but for the vision research team of the Burke-Blythedale Pediatric Neuroscience Research Collaboration, plugging in and pumping up the volume is just part of the job when working with Valentino Guidi.

Born a healthy baby in 2006, Valentino reached all the regular developmental milestones. At the age of three-and-a-half, however, he nearly drowned causing a severe brain injury. After the tragic event, Valentino was unable to sit or stand, to feed himself, or to communicate. His parents also did not know whether he could see and wanted him to become more visually aware. After months of therapies and treatments in his home city of Hong Kong, Valentino became stable enough to travel, and his parents sought medical opinions in New York, where Valentino’s mother, Sandra Lee, grew up.

“We started to look for options and met plenty of clinicians that looked at Valentino and within one second decided he couldn’t do anything and told us to just accept it,” said Ms. Lee. The search for answers led them to Dr. Jason Carmel, a pediatric neurologist and assistant professor of neuroscience in pediatrics at Burke Medical Research Institute, Weill Cornell Medicine. Knowing that the goal for Valentino was to become more visually aware, Dr. Carmel consulted with a Burke colleague, Glen Prusky, Ph.D., professor and director of the Laboratory for Visual Disease and Therapy at Burke Medical Research Institute, Weill Cornell Medicine.

Dr. Prusky created a system for testing vision in mice or rats. To test vision, rodents are placed in front of a computer screen displaying moving black and white bars. If the rodent can see the moving bars, the computer system follows the rodent’s eye movement via a webcam. The bars are adjusted to become narrower and with less contrast to determine the range and limits of vision function. If a rodent’s eyes no longer follow the bars on the screen then we know what the rodent is unable to see. When Ms. Lee saw this system in use, she said, “My son can do that.”

“We modified the rodent system to be child size for Valentino and placed the system in front of Valentino. We watched his eyes through the webcam to decide if his eyes were able to follow and track the moving bars smoothly,” said Dr. Prusky. This helped researchers confirm to Valentino’s parents that he could, in fact, see!

The team replaced the webcam with eye tracking technology to improve the vision assessment tool. Jeremy Hill, D. Phil., an Instructor at Burke Medical Research Institute, created the system based on the principles that Dr. Prusky had established. “We took a computer monitor and software that presented visual stimuli, developed an algorithm that gathered input from an eye-tracking device to determine if a person’s eye movement was smooth and then connected it to a system that played or paused music,” said Dr. Hill. Dr. Prusky added, “We now call the system OptokineSys. It enables us to measure visual function in children who cannot communicate about their range of vision abilities.”

In 2015, the Burke Medical Research Institute partnered with Blythedale Children’s Hospital to bring neurosciences advances to children with neurological impairments through the Burke-Blythedale Pediatric Neuroscience Research Collaboration. Together with Valentino’s family a new research program, the Vision Recovery Program, was established to help engage Valentino through vision recovery. This enabled OptokineSys to be tested with other children who are at risk of low vision due to brain injury. It is estimate that a quarter of children with low vision have diminished function because of a brain problem, rather than an eye problem. This system should allow accurate diagnosis of this disorder, improved understanding of how vision changes over time in affected children, and perhaps improved therapy.

“We’ve now tested over 40 children at Blythedale Children’s Hospital,” said Dr. Carmel, who directs the Burke-Blythedale collaboration. “We can, for the first time, know how well a child can see, even if they cannot communicate.” The team has also begun to measure vision changes as children grow and develop. Dr. Prusky continues to investigate and research advancements for vision recovery and has found that in rodents, giving repeated testing on this system as therapy indeed improved their vision function. The research team plans to test the hypothesis that delivering visual stimulation at the threshold of ability can in fact improve vision function.

Valentino has used OptokineSys regularly over the years since it was developed. He has shown that it is possible to repeatedly measure vision in children who cannot communicate. It is also possible to engage children with the computer system, largely using music reward. “One of Valentino’s functions that was left intact and quite sharp, was his hearing and his taste in music. That really motivates him,” said Ms. Lee. Techno and dance music are some of his favorites. The research team has seen a measurable increase in Valentino’s visual function over the years that he has been using it, although only a formal trial will determine if the system is effective. This offers hope and aspiration for Valentino and the large number of children with vision loss due to brain injury, that a therapy will one day be possible. Today, using OptokineSys, the music beat continues to pump up the volume.

For more information on the Burke-Blythedale Pediatric Neuroscience Research Collaboration, or about the OptokineSys program visit burke.weill.cornell.edu/burke-blythedale or blythedale.org/vision  or please contact Dr. Jason Carmel at jason.carmel@med.cornell.edu or (914) 368-3135.